로딩 중…
지수 로딩 중…
Ironwood Pharmaceuticals, Inc.
IRWD· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$3.54+0.57%
2026-06-18
Price Chart
Ironwood Pharmaceuticals, Inc.+406.58%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $583M |
| Revenue | $362M |
| Net Income | $102M |
| Total Assets | $435M |
| Net Assets | $707M |
| Value | |
| P/E | 5.70x |
| P/B | 0.82x |
| PEG | 0.00x |
| P/S | 1.61x |
| EV/EBITDA | 4.67x |
| FCF Yield | 19.26% |
| Profitability | |
| ROE | 14.46% |
| ROA | 23.51% |
| Op. Margin | 55.83% |
| Revenue Growth | 158.87% |
| Earnings Growth | 2629.20% |
| Financial Health | |
| Debt Ratio | 92.20% |
| Total Debt | $597M |
| FCF | $112M |
| Cash | $220M |
| Current Ratio | 1.41x |
| Net Debt/EBITDA | 1.83x |
| Performance | |
| 1Y Return | 406.58% |
| 1M Return | -3.54% |
| From 52W High | -38.75% |
| 1Y MDD | -55.11% |
| Trading | |
| Volume | 2,697,013 shares |
| Trading Value | $10M |
| Per Share | |
| EPS | $0.15 |